Ligand Pharmaceutical Inc (+N, LGND US, September 26th)
Todd Davis (CEO since 2022; Director since 2007) made his largest purchase, spending $238,000 on September 22nd at $59.38 and increasing his holdings by +4% to 73,090 shares. Davis has made two prior purchases, in August 2019 at $58 and in August 2011 at $7, both when he was a director, and both were timely.
His track record as a seller is even more impressive, and his last sale was in Feb. 2021 at $133. This is his first purchase since he took over as CEO in December 2022.
We are ranking the stock +N.